Global Recombinant Collagen Market Growth 2025-2031
Description
The global Recombinant Collagen market size is predicted to grow from US$ 229 million in 2025 to US$ 4718 million in 2031; it is expected to grow at a CAGR of 65.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Recombinant collagen is a template based on the amino acid sequence of collagen in organisms. It is designed reasonably, cut and spliced, and then transferred to engineered cells mainly composed of E. coli and Pichia with the help of synthetic biology technology, and the obtained collagen is prepared using the rapid production capacity of engineered cells. If human collagen is used as a template, the recombinant collagen obtained by design and splicing is called recombinant human collagen.
Technical breakthroughs have promoted the continuous expansion of the application field of recombinant collagen, from the initial functional skin care products to scalp care products, health foods for sports recovery and beauty. Professor Sun Lingyun's team and Yang Yang used recombinant collagen as raw material to build tissue engineering scaffolds using biological cell 3D printing and electrospinning, expanding the scope of application research on recombinant collagen in the field of regenerative medicine. In order to standardize the development of the industry, the State Food and Drug Administration has successively issued a number of industry standards and policies, respectively making standardized requirements for the naming of recombinant collagen biomaterials, product supervision and management, and quality control. In March 2021, the "Guiding Principles for Naming Recombinant Collagen Biomaterials" was promulgated; in April 2021, the "Principles for Classification of Recombinant Collagen Medical Products" was promulgated; in August 2022, the "Recombinant Collagen" industry standard was officially implemented; in July 2023, the "Recombinant Humanized Collagen" medical device industry standard was officially implemented. In order to better guide and standardize the naming of recombinant collagen medical devices, in January 2023, the Medical Device Standard Management Center of the State Drug Administration also issued an interpretation of the "Guiding Principles for the Naming of Recombinant Collagen Biomaterials".
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Collagen Industry Forecast” looks at past sales and reviews total world Recombinant Collagen sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Collagen sales for 2025 through 2031. With Recombinant Collagen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Collagen industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Collagen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Collagen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Collagen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Collagen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Collagen.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Collagen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Recombinant Type I Collagen
Recombinant Type III Collagen
Recombinant Type XVII Collagen
Segmentation by Application:
Biomedicine
Beauty and Skin Care
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
Evonik
ProColl
CollPlant
Creative BioMart
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Collagen market?
What factors are driving Recombinant Collagen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Collagen market opportunities vary by end market size?
How does Recombinant Collagen break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Recombinant collagen is a template based on the amino acid sequence of collagen in organisms. It is designed reasonably, cut and spliced, and then transferred to engineered cells mainly composed of E. coli and Pichia with the help of synthetic biology technology, and the obtained collagen is prepared using the rapid production capacity of engineered cells. If human collagen is used as a template, the recombinant collagen obtained by design and splicing is called recombinant human collagen.
Technical breakthroughs have promoted the continuous expansion of the application field of recombinant collagen, from the initial functional skin care products to scalp care products, health foods for sports recovery and beauty. Professor Sun Lingyun's team and Yang Yang used recombinant collagen as raw material to build tissue engineering scaffolds using biological cell 3D printing and electrospinning, expanding the scope of application research on recombinant collagen in the field of regenerative medicine. In order to standardize the development of the industry, the State Food and Drug Administration has successively issued a number of industry standards and policies, respectively making standardized requirements for the naming of recombinant collagen biomaterials, product supervision and management, and quality control. In March 2021, the "Guiding Principles for Naming Recombinant Collagen Biomaterials" was promulgated; in April 2021, the "Principles for Classification of Recombinant Collagen Medical Products" was promulgated; in August 2022, the "Recombinant Collagen" industry standard was officially implemented; in July 2023, the "Recombinant Humanized Collagen" medical device industry standard was officially implemented. In order to better guide and standardize the naming of recombinant collagen medical devices, in January 2023, the Medical Device Standard Management Center of the State Drug Administration also issued an interpretation of the "Guiding Principles for the Naming of Recombinant Collagen Biomaterials".
LP Information, Inc. (LPI) ' newest research report, the “Recombinant Collagen Industry Forecast” looks at past sales and reviews total world Recombinant Collagen sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Collagen sales for 2025 through 2031. With Recombinant Collagen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Collagen industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Collagen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Collagen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Collagen market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Collagen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Collagen.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Collagen market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Recombinant Type I Collagen
Recombinant Type III Collagen
Recombinant Type XVII Collagen
Segmentation by Application:
Biomedicine
Beauty and Skin Care
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Giant Biogene
Shanxi Jinbo Bio-Pharmaceutical
Jiangsu JLand Biotech
Jiangsu Chuangjian Medical Technology
Evonik
ProColl
CollPlant
Creative BioMart
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Collagen market?
What factors are driving Recombinant Collagen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Collagen market opportunities vary by end market size?
How does Recombinant Collagen break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
87 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Recombinant Collagen by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Recombinant Collagen by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.